CTOs on the Move

Daily Cardinal Alumni Association

www.dailycardinal.net

 
Daily Cardinal Alumni Association is a Oak Park, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Atrium Health

Atrium Health, formerly Carolinas HealthCare System, is a not for profit hospital network which operates hospitals, freestanding emergency departments, urgent care centers, and medical practices in the American states of North Carolina, South Carolina ...

Parmer Eye Care

Parmer Eye Care is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Zufall Health Center

Zufall Health Center is a Dover, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Herbalife

Herbalife Nutrition is a global nutrition company that has been helping people get healthier and happier since 1980. We operate in more than 90 countries worldwide and our products are sold exclusively by Herbalife Nutrition Independent Distributors. Our nutrition philosophy is simple: Combine balanced nutrition with a healthy, active life, and the one-on-one support of an Herbalife Independent Distributor. At Herbalife Nutrition, we source ingredients, such as aloe and tea, from select agricultural regions around the world. We have selected world-class micronutrient suppliers and are the largest purchaser of soy protein isolate in the United States. Our staff, state-of-the-art equipment and quality control systems help to ensure that every product meets our exacting quality standards which are among the highest in the industry. We support the Herbalife Family Foundation (HFF) and its Casa Herbalife programs to help bring balanced nutrition to children in need. Herbalife Nutrition also sponsors more than 190 world-class athletes, teams and events around the globe, including Cristiano Ronaldo, the LA Galaxy and champions in many other sports.

Imagin Medical

Imagin Medical is developing imaging solutions for the early detection of cancer through the use of endoscopes. The Company believes it will radically improve the way physicians detect cancer. Imagin`s initial target market is bladder cancer, a major cancer worldwide, the sixth most prevalent in the U.S., and the most costly cancer to treat due to a greater than 50% recurrence rate. Developed at the Lawrence Livermore National Laboratory, this advanced, ultrasensitive imaging technology is based upon improved optical designs and advanced light sensors.